Evidence-based·Updated November 16, 2026·How we grade evidence

Escitalopram

MedicationSSRI antidepressant (prescription)

Escitalopram is a widely used SSRI. A network meta-analysis of 522 trials found all antidepressants beat placebo for depression, with escitalopram among the more effective and better tolerated in head-to-head trials, and a second network meta-analysis found it effective for generalized anxiety disorder. St. John's wort is the critical supplement interaction; cannabis products are a high-severity concern and saffron a low one.

Prescription medication: not a dietary supplement

This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.

Quick decision guide

May help most

Adults and teens with major depression, or adults and children 7 and older with generalized anxiety disorder, whose prescriber recommends an SSRI

Common dosing range

Set by your prescriber. The Lexapro label recommends 10 mg once daily, with a maximum of 20 mg once daily; 10 mg is the recommended dose for most older adults and people with liver problems

When to expect effects

The trials that established it lasted 8 weeks; in one anxiety trial, improvement over placebo was measurable from week 1

Watch out for

Boxed warning for suicidal thoughts and behaviors in children, teens and young adults. Never combine with MAO inhibitors or pimozide. Raises serotonin syndrome risk with St. John's wort and other serotonergic products, and bleeding risk with blood thinners and NSAIDs. Do not stop suddenly: the label recommends a gradual reduction set by your prescriber

What is it

Escitalopram is a prescription antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is sold as generic escitalopram tablets and under the brand name Lexapro. The Lexapro label approves it for major depressive disorder in adults and children 12 years and older, and for generalized anxiety disorder in adults and children 7 years and older. It is the S-isomer, the active half, of the older antidepressant citalopram.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You have major depression or generalized anxiety disorder and your prescriber recommends an SSRI
You can keep follow-up visits to check mood and side effects, especially in the first months and after dose changes
You are willing to review every supplement, cannabis product and over-the-counter medicine with your doctor or pharmacist

Probably skip if…

You take an MAO inhibitor or stopped one in the last 14 days, or you take pimozide (both contraindicated)
You have had an allergic reaction to escitalopram or citalopram
You want to keep taking St. John's wort or other serotonin-boosting supplements without telling your prescriber
You often miss doses or may stop suddenly, which can cause discontinuation symptoms

Evidence at a glance

major depressive disorder

Good Evidence
Effect
Modest; response odds about 1.4 to 2.1 times placebo across antidepressants
Best fit
Adults with moderate to severe major depression
Time
Measured over acute treatment trials, typically about 8 weeks

generalized anxiety disorder

Good Evidence
Effect
Modest; about 2.5 points more improvement on the Hamilton Anxiety Scale than placebo
Best fit
Adult outpatients with generalized anxiety disorder
Time
Improvement over placebo from week 1 in one trial; trials lasted 8 weeks

preventing relapse after response

Good Evidence
Effect
Large in anxiety (19% vs 56% relapse) and moderate in depression (26% vs 40%)
Best fit
Adults who have already responded well to escitalopram
Time
Measured over 36 weeks (depression) and 24 to 76 weeks (anxiety)

Evidence for 3 uses

AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.

major depressive disorder

Disease adjunct
Good Evidence

A 2018 network meta-analysis of 522 double-blind trials with 116,477 adults found that all 21 antidepressants studied were more effective than placebo for acute treatment of major depression, with odds ratios from 1.37 to 2.13. In head-to-head trials, escitalopram was among the more effective drugs and also among the better tolerated, with fewer dropouts than many others. The authors rated the certainty of evidence moderate to very low overall. The review left out trials in which 20% or more of participants had bipolar, psychotic or treatment-resistant depression.

Effect size
Modest; response odds about 1.4 to 2.1 times placebo across antidepressants
Time to effect
Measured over acute treatment trials, typically about 8 weeks
Best fit
Adults with moderate to severe major depression
Less likely
People with bipolar depression, psychotic depression or treatment-resistant depression, who were largely excluded from the trials

Bottom line: Escitalopram works better than placebo for depression and is one of the better tolerated options.

generalized anxiety disorder

Disease adjunct
Good Evidence

A 2019 network meta-analysis of 89 randomized trials with 25,441 adult outpatients found escitalopram more effective than placebo for generalized anxiety disorder, lowering the Hamilton Anxiety Scale score by 2.45 points more (95% credible interval 1.63 to 3.27), with relatively good acceptability. In one 8-week trial of 315 adults, 58% responded on escitalopram 10 to 20 mg a day compared with 38% on placebo, and improvement was measurable from week 1.

Effect size
Modest; about 2.5 points more improvement on the Hamilton Anxiety Scale than placebo
Time to effect
Improvement over placebo from week 1 in one trial; trials lasted 8 weeks
Best fit
Adult outpatients with generalized anxiety disorder
Less likely
People needing proof of long-term benefit from short trials alone

Bottom line: Escitalopram is one of several drugs that reliably ease generalized anxiety, by a modest margin.

preventing relapse after response

Disease adjunct
Good Evidence

Two randomized trials tested staying on escitalopram after it had worked. In 274 adults whose depression responded, relapse over 36 weeks was 26% on continued escitalopram versus 40% on placebo (hazard ratio 0.56). In 375 adults whose generalized anxiety responded to 20 mg a day, 19% relapsed on continued escitalopram versus 56% on placebo over 24 to 76 weeks. Both trials enrolled only people who had already responded to escitalopram.

Effect size
Large in anxiety (19% vs 56% relapse) and moderate in depression (26% vs 40%)
Time to effect
Measured over 36 weeks (depression) and 24 to 76 weeks (anxiety)
Best fit
Adults who have already responded well to escitalopram
Less likely
People who did not respond in the first weeks of treatment, who were not studied

Bottom line: For people it helps, continuing escitalopram lowers the chance of the illness coming back.

How it works

Escitalopram blocks the reuptake of serotonin in the brain, so this chemical messenger stays active longer. The label says this is thought to explain its effect in depression and anxiety. It is broken down mainly in the liver by the enzymes CYP3A4 and CYP2C19, and its half-life is about 27 to 32 hours, which is why it is taken once a day. Because it raises serotonin, the main supplement risk is serotonin syndrome when it is combined with other products that also raise serotonin, such as St. John's wort or tryptophan. Drugs that affect serotonin reuptake also make bleeding more likely, which matters for people who also take blood thinners, aspirin or NSAID pain relievers.

How to take it

1. Typical dose
Your prescriber sets the dose. For depression and for generalized anxiety disorder, the Lexapro label recommends 10 mg once daily in adults. Depending on response and tolerability it may be raised to the maximum of 20 mg once daily after at least 1 week in adults (at least 3 weeks for teens with depression and at least 2 weeks for children with anxiety). For most older adults and people with liver impairment the recommended dose is 10 mg once daily. For depression, a fixed-dose trial found no greater benefit from 20 mg than from 10 mg.
2. Higher studied dose
The label maximum is 20 mg once daily. A heart-rhythm study tested 30 mg a day in healthy volunteers, which is above the approved dose.
3. Timing
Once daily, in the morning or the evening, at about the same time each day.
4. With food
The label says it can be taken with or without food; food does not affect absorption.
5. Split dosing
Not needed. It is a once-daily medicine.
6. How long to try
Your prescriber decides how long. In a relapse-prevention trial, people who kept taking escitalopram after responding had fewer relapses over 36 weeks than those switched to placebo. When it is time to stop, the label recommends a gradual dose reduction rather than stopping abruptly, planned with your prescriber.

What to track

Mood changes, new or worse depression, anxiety, agitation or suicidal thoughts, especially early on and after dose changes (contact your provider right away)
Agitation, tremor, sweating, fever, fast heartbeat or diarrhea, which can signal serotonin syndrome, especially after adding a supplement or new medicine
Unusual bruising or bleeding, especially if you also take aspirin, NSAIDs or a blood thinner
Headache, confusion, weakness or unsteadiness, which can signal low sodium, particularly in older adults
Symptoms after a missed dose or dose reduction, such as dizziness, irritability or electric-shock sensations

Bottom line: Your prescriber sets the dose; take it once a day, with or without food, and never stop suddenly on your own.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Nausea, diarrhea, dry mouth and indigestionTrouble sleeping, or sleepiness and tirednessIncreased sweating and dizzinessSexual problems: delayed ejaculation, lower libido, erectile problems and delayed or absent orgasm

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Pregnancy: the Lexapro label says published studies and postmarketing reports have not established an increased risk of major birth defects or miscarriage. SSRI use, particularly in the month before delivery, has been linked to a less than 2-fold higher risk of heavy bleeding after birth, and use later in pregnancy may increase the risk of persistent pulmonary hypertension in the newborn and of breathing, feeding or temperature problems after birth. Untreated depression also carries risks, and women who stop antidepressants are more likely to relapse. Breastfeeding: escitalopram and its metabolite pass into breast milk (in a study of 8 mothers, infants received about 3.9% of the maternal weight-adjusted dose), and there are reports of excess sedation, restlessness, poor feeding and poor weight gain in exposed infants; the label says to weigh the benefits of breastfeeding against the mother's need for treatment and to monitor the infant.

Interactions

St. John's wortCritical

The Lexapro label lists St. John's wort among serotonergic products that raise the risk of serotonin syndrome, a potentially life-threatening reaction, with escitalopram. A systematic review of St. John's wort interactions also identified possible serotonergic interactions with SSRIs; it can also speed up drug-clearing liver enzymes, including CYP3A4, which the Lexapro label names as one of the main enzymes that clear escitalopram, though these sources do not report its effect on escitalopram levels. Do not combine them without your prescriber's advice, and if you already take both, contact your prescriber rather than stopping anything on your own.

L-tryptophanCritical

The Lexapro label says combining escitalopram with tryptophan, the amino acid the body turns into serotonin, increases the risk of serotonin syndrome, a potentially life-threatening reaction, and its highlights say the combination is not recommended. No case with this exact pair has been published. Do not add a tryptophan supplement unless your prescriber advises it, and seek emergency care for agitation, tremor, fever, fast heartbeat, heavy sweating or muscle stiffness.

5-HTP (5-hydroxytryptophan)Critical

5-HTP is the body's direct building block for serotonin, so it adds to escitalopram's serotonin effect. The Lexapro label names tryptophan, the amino acid the body turns into 5-HTP, among products that increase the risk of serotonin syndrome; it does not name 5-HTP itself, and no escitalopram case has been published. Do not combine them unless your prescriber directs it, and seek emergency care for agitation, tremor, fever, fast heartbeat, heavy sweating or muscle stiffness.

MAO inhibitors (such as phenelzine, tranylcypromine, selegiline, linezolid, intravenous methylene blue)Critical

Contraindicated because of the risk of serotonin syndrome. The label requires at least 14 days between stopping an MAOI and starting escitalopram, and at least 14 days after stopping escitalopram before starting an MAOI.

PimozideCritical

Contraindicated. Racemic citalopram raised levels of pimozide, a drug with a narrow safety margin, which may increase the risk of QT prolongation and dangerous heart rhythms.

Cannabis and CBD productsHigh

Cannabidiol (CBD) blocked the enzymes that break down citalopram and escitalopram in lab tests, and in 6 patients taking citalopram or escitalopram, adding CBD raised their drug levels; in 20 healthy adults, CBD raised citalopram exposure by about 43%. A case report describes repeated serotonin syndrome in a man taking fluoxetine (another antidepressant) after high-THC cannabis oil or a THC vape, and cites similar recent cases in people taking antidepressants. Tell your prescriber about any cannabis or CBD use, and seek urgent care for agitation, tremor, sweating, fever or a fast heartbeat.

Aspirin, NSAIDs (ibuprofen, naproxen), warfarin and other blood thinnersHigh

Escitalopram increases bleeding risk, and the label says aspirin, NSAIDs, other antiplatelet drugs, warfarin and other anticoagulants may add to it. People on warfarin need careful INR monitoring. Ask your pharmacist before using an over-the-counter pain reliever.

AlcoholModerate

In a clinical trial, escitalopram did not increase alcohol's effects on thinking and coordination, but the Lexapro label still recommends against alcohol, and its Medication Guide says not to drink during treatment. Both can affect alertness, so do not drive after drinking. One case of serotonin syndrome after a can of beer involved escitalopram plus a second antidepressant, clomipramine; a single case is a signal, not proof. Be honest with your prescriber about drinking, and do not stop escitalopram on your own.

Saffron (supplements)Low

Saffron may act partly on serotonin, which raises a theoretical concern about added effects with escitalopram. In an 8-week trial of 160 adults already taking an antidepressant, adding a standardized saffron extract improved clinician-rated depression scores and did not worsen antidepressant side effects; the trial did not report results for escitalopram users separately. Discuss it with your prescriber before using a saffron supplement.

Documented interactions

Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.

Warnings (4)

+ 5-htp

critical

Escitalopram is a selective serotonin reuptake inhibitor (SSRI) that keeps serotonin active longer, and 5-HTP (5-hydroxytryptophan) is the direct building block the body turns into serotonin, so taking both can push serotonin activity too high and cause serotonin syndrome, a potentially life-threatening reaction. The Lexapro label names tryptophan, the amino acid the body turns into 5-HTP, among serotonergic drugs that increase this risk; it does not name 5-HTP itself. No case with escitalopram and 5-HTP was found; the concern rests on the label, the shared mechanism and a published case of serotonin syndrome when 5-HTP was taken with sertraline, another SSRI.

+ st. john's wort

critical

Escitalopram is an SSRI cleared mainly by CYP2C19 and CYP3A4. St. John's wort independently raises serotonin and speeds up those same enzymes in people. Taken together, the combination can trigger serotonin syndrome, a potentially life-threatening reaction, and the escitalopram label lists St. John's Wort among the drugs that raise this risk. St. John's wort could also lower escitalopram levels, but no study has measured this. Published serotonin syndrome cases involve other antidepressants rather than escitalopram specifically.

+ tryptophan

critical

Escitalopram is a selective serotonin reuptake inhibitor (SSRI) that keeps serotonin active longer, and L-tryptophan is the amino acid the body turns into serotonin, so taking both can push serotonin activity too high. The Lexapro label says combining escitalopram with other serotonergic drugs, naming tryptophan in the same list as St. John's wort, increases the risk of serotonin syndrome, a potentially life-threatening reaction. Its highlights say use with tryptophan is not recommended. No published case with this exact pair was found; the rating follows the label warning and matches the rating for tryptophan with sertraline, fluoxetine and venlafaxine.

+ alcohol

moderate

The Lexapro label says escitalopram did not increase alcohol's effects on thinking and coordination in a clinical trial, but it still recommends against alcohol, and the Medication Guide says not to drink during treatment. Escitalopram can itself cause sleepiness or slow thinking and reactions, and alcohol adds its own impairment. One published case described serotonin syndrome after a can of beer in a man taking escitalopram with a second antidepressant, clomipramine; a single case is a signal, not proof.

See all 4 Escitalopram interactions →

Choosing a product

What to look for on the label, and what to be skeptical of.

Look for…

Generic escitalopram or Lexapro dispensed by a licensed pharmacy on your own prescription
The strength on the label (tablets come in 5, 10 and 20 mg)
A Medication Guide with each fill, which explains the suicidality warning
Pharmacy instructions to take it once daily and not to stop suddenly

Be skeptical of…

Mood or "serotonin support" supplements containing St. John's wort, tryptophan or 5-HTP presented as safe with antidepressants
CBD or cannabis products marketed as having no drug interactions
Products claiming to be a natural replacement for escitalopram, or advice to switch to herbs and stop the medicine
Online sellers offering escitalopram without a prescription

Frequently asked questions

Can I take St. John's wort with escitalopram?⌄

This page rates it a critical interaction. The Lexapro label lists St. John's wort among products that raise the risk of serotonin syndrome with escitalopram. Talk to your prescriber before using it, and if you have been combining them, contact your prescriber rather than stopping anything on your own.

Is CBD or cannabis safe with escitalopram?⌄

This page rates it high severity. CBD raised citalopram and escitalopram levels in small studies, and high-potency THC cannabis has been linked to serotonin syndrome in people on other antidepressants. Tell your prescriber about any cannabis or CBD use so they can watch for side effects.

Can I drink alcohol while taking escitalopram?⌄

In a study, escitalopram did not worsen the effects of alcohol on thinking and coordination, but the label still says alcohol is not recommended during treatment. Alcohol can also make depression and anxiety harder to treat, so be open with your prescriber about how much you drink.

Is saffron safe with escitalopram?⌄

The concern is theoretical. In a trial of adults already on antidepressants, adding saffron did not worsen side effects, but results for escitalopram were not reported separately. This page rates it low severity. Ask your prescriber before starting a saffron supplement.

What happens if I stop escitalopram suddenly?⌄

Stopping suddenly can cause discontinuation symptoms such as dizziness, irritability, anxiety, headache and electric-shock sensations. The label recommends a gradual reduction rather than stopping abruptly. Talk to your prescriber before making any change.

References by claim

major depressive disorder

Cipriani et al., 2018 · PMC (2018) link

generalized anxiety disorder

Slee et al., 2019 · PubMed (2019) link

Davidson et al., 2004 · PubMed (2004) link

preventing relapse after response

Rapaport et al., 2004 · PubMed (2004) link

Allgulander et al., 2006 · PubMed (2006) link

Safety

Lexapro (escitalopram) tablets prescribing information · DailyMed (FDA label) link

Interaction: St. John's wort

Henderson et al., 2002 · PMC (2002) link

Interaction: 5-HTP (5-hydroxytryptophan)

Patel et al., 2017 · PMC (2017) link

Interaction: Cannabis and CBD products

Anderson et al., 2021 · PubMed (2021) link

Salcedo et al., 2026 · PMC (2026) link

Nadeem et al., 2024 · PMC (2024) link

Interaction: Alcohol

Suzuki et al., 2019 · PubMed (2019) link

Interaction: Saffron (supplements)

Lopresti et al., 2019 · PubMed (2019) link

Track Escitalopram with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora app.

Evidence-based·Updated Nov 16, 2026·Evidence current as of Nov 16, 2026·How we grade evidence

Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.